Clinical Indicators for Coders/CDI The following indicators, when present in physician documentation, laboratory values, or diagnostic reports, support assignment of a Crohns disease diagnosis and may trigger CDI queries for greater specificity: When imaging or operative reports document a fistula, abscess, or bowel obstruction in a patient with known Crohns disease, and the attendings Crohns diagnosis code lacks a complication specifier, query the provider: Does the patients current admission involve Crohns disease with [fistula / abscess / obstruction / rectal bleeding] as a complication of the Crohns, a separate condition, or both? This distinction determines whether to code K50.x13, K50.x14, K50.x12, or K50.x11 vs
BPC-157 appears to interact with the function of various growth factors, including vascular endothelial growth factor (VEGF)
$350.00 every 4 weeks An injectable blend of Tirzepatide for metabolic health and Vitamin B12 for energy support
BPC-157 / TB-500 Mix Research Peptide Blend (Lyophilised, HPLC 99%) Laboratory Research Use HPLC & MS Verified UK Dispatch, Tracked COA Available On Request Research Handling Note: To achieve optimal results in your research, we recommend bringing both the peptide and your selected solvent to standard laboratory room temperature prior to reconstitution
Research peptide BPC-157 + TB-500 Nasal Spray Laboratory research material for analytical / in-vitro research use only